Tonix Pharmaceuticals Holding Corp. - 10-Q Filing
Tonix Pharmaceuticals reports Q3 2026 financial results with segment performance across Tonmya, Zembrace Symtouch, and Tosymra.
Tonix Pharmaceuticals reports Q3 2026 financial results with segment performance across Tonmya, Zembrace Symtouch, and Tosymra.